Mutant Allele Frequency-Based Intra-Tumoral Genetic Heterogeneity Related to the Tumor Shrinkage Mode After Neoadjuvant Chemotherapy in Breast Cancer Patients

11Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

The shrinkage mode of tumor extent after neoadjuvant chemotherapy (NAC) is an important index to evaluate the odds of breast-conserving surgery. However, there is no sufficient measurement to predict the shrinkage mode after NAC. In this study, we analyzed 24 patients' formalin-fixed, paraffin-embedded samples before and after treatment and analyzed 456 cancer-related genes panel by using target next-generation sequencing. Meanwhile, the pathological shrinkage mode was reconstructed in three dimensions after surgery, and the genetic heterogeneity level was estimated by mutant-allele tumor heterogeneity (MATH). We measured the genetic intra-tumor heterogeneity and explored its correlation with the shrinkage mode after NAC. A total of 17 matched pair samples of primary tumor tissue and residual tumor tissue were successfully accessed. It was found that the most common mutated genes were TP53 and PIK3CA in both samples before and after NAC, and no recurrent mutations were significantly associated with the shrinkage mode. Besides, the MATH value of formalin-fixed, paraffin-embedded samples before and after NAC was analyzed by the area under the curve of the receiver operating characteristic, and it is feasible to classify patients into concentric shrinkage mode and non-concentric shrinkage mode in NAC based on the MATH threshold of 58. Our findings indicate that the MATH value was associated with the shrinkage mode of breast cancer in a non-linear model. Patients with the MATH value below the threshold of 58 before and after NAC displayed a concentric shrinkage mode. The area under the curve was 0.89, with a sensitivity of 0.69 and specificity of 1. Our study might provide a promising application of intra-tumor heterogeneity that is measured by MATH to make a choice of surgery.

References Powered by Scopus

The Sequence Alignment/Map format and SAMtools

41091Citations
N/AReaders
Get full text

Fast and accurate short read alignment with Burrows-Wheeler transform

34811Citations
N/AReaders
Get full text

Cancer statistics, 2019

17474Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Tumor-promoting aftermath post-chemotherapy: A focus on breast cancer

19Citations
N/AReaders
Get full text

Radiomics Based on DCE-MRI for Predicting Response to Neoadjuvant Therapy in Breast Cancer

11Citations
N/AReaders
Get full text

Radiomics Based on Dynamic Contrast-Enhanced MRI to Early Predict Pathologic Complete Response in Breast Cancer Patients Treated with Neoadjuvant Therapy

10Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Zheng, C. H., Liu, Z. Y., Yuan, C. X., Dong, X. Y., Li, H. M., Wang, J. J., … Wang, Y. S. (2021). Mutant Allele Frequency-Based Intra-Tumoral Genetic Heterogeneity Related to the Tumor Shrinkage Mode After Neoadjuvant Chemotherapy in Breast Cancer Patients. Frontiers in Medicine, 8. https://doi.org/10.3389/fmed.2021.651904

Readers over time

‘21‘22‘23‘2401234

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 1

100%

Readers' Discipline

Tooltip

Medicine and Dentistry 1

50%

Pharmacology, Toxicology and Pharmaceut... 1

50%

Save time finding and organizing research with Mendeley

Sign up for free
0